NO20000822L - Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander - Google Patents
Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorliganderInfo
- Publication number
- NO20000822L NO20000822L NO20000822A NO20000822A NO20000822L NO 20000822 L NO20000822 L NO 20000822L NO 20000822 A NO20000822 A NO 20000822A NO 20000822 A NO20000822 A NO 20000822A NO 20000822 L NO20000822 L NO 20000822L
- Authority
- NO
- Norway
- Prior art keywords
- substituted
- agonists
- carboxamides
- oxo
- receptor ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Anesthesiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91818097A | 1997-08-25 | 1997-08-25 | |
PCT/US1998/017513 WO1999010347A1 (en) | 1997-08-25 | 1998-08-24 | Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20000822D0 NO20000822D0 (no) | 2000-02-18 |
NO20000822L true NO20000822L (no) | 2000-04-13 |
Family
ID=25439933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20000822A NO20000822L (no) | 1997-08-25 | 2000-02-18 | Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1007526A1 (pt) |
JP (1) | JP2001514181A (pt) |
KR (1) | KR20010023313A (pt) |
CN (1) | CN1268136A (pt) |
AP (1) | AP2000001742A0 (pt) |
AU (1) | AU753800B2 (pt) |
BG (1) | BG104192A (pt) |
BR (1) | BR9811362A (pt) |
CA (1) | CA2301599C (pt) |
EG (1) | EG21717A (pt) |
HU (1) | HUP0003258A3 (pt) |
IL (1) | IL134291A0 (pt) |
IS (1) | IS5382A (pt) |
LV (1) | LV12539B (pt) |
NO (1) | NO20000822L (pt) |
NZ (1) | NZ502548A (pt) |
OA (1) | OA11293A (pt) |
PE (1) | PE130999A1 (pt) |
PL (1) | PL338783A1 (pt) |
SI (1) | SI20270A (pt) |
SK (1) | SK2162000A3 (pt) |
TW (1) | TW574221B (pt) |
WO (1) | WO1999010347A1 (pt) |
YU (1) | YU10500A (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0010308A (pt) * | 1999-05-06 | 2002-01-08 | Neurogen Corp | Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento de uma doença ou distúrbio associados com o agonismo patogênico, agonismo inverso ou antagonismo do receptor de gabaa, para localizar receptores de gabaa em uma amostra de tecido, para inibir a ligação de um composto de benzodiazepina a um receptor de gabaa e para alterar a atividade da transdução de sinal dos receptores de gabaa, e, composição farmacêutica embalada |
WO2000071528A1 (en) * | 1999-05-25 | 2000-11-30 | Neurogen Corporation | 4h-1,4-benzothiazine-2-carboxamides and their use as gaba brain receptor ligands |
US6562822B2 (en) | 2000-07-12 | 2003-05-13 | Pharmacia & Upjohn Company | Heterocyle carboxamides as antiviral agents |
US6730682B2 (en) | 2000-07-12 | 2004-05-04 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
US6559145B2 (en) | 2000-07-12 | 2003-05-06 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
ATE364385T1 (de) | 2000-10-12 | 2007-07-15 | Merck & Co Inc | Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer |
IL155089A0 (en) | 2000-10-12 | 2003-10-31 | Merck & Co Inc | Aza and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
EP1326610B1 (en) | 2000-10-12 | 2006-11-15 | Merck & Co., Inc. | Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
US20020151591A1 (en) * | 2000-10-17 | 2002-10-17 | Anabella Villalobos | Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders |
KR20030076717A (ko) * | 2001-03-01 | 2003-09-26 | 화이자 프로덕츠 인크. | 인지 장애의 치료를 위한 니코틴 수용체 부분 아고니스트,에스트로겐, 선택적 에스트로겐 조정자 또는 비타민 e와함께, gabaa 역아고니스트의 용도 |
AR036256A1 (es) | 2001-08-17 | 2004-08-25 | Merck & Co Inc | Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento |
ES2291642T3 (es) | 2002-01-17 | 2008-03-01 | MERCK & CO., INC. | Hidroxinaftiridinoncarboxamidas utiles como inhibidores de la integrasa de vih. |
JP4494020B2 (ja) | 2002-03-15 | 2010-06-30 | メルク・シャープ・エンド・ドーム・コーポレイション | Hivインテグラーゼ阻害剤として有用なn−(置換ベンジル)−8−ヒドロキシ−1,6−ナフチリジン−7−カルボキサミド |
WO2004106336A1 (en) * | 2003-05-27 | 2004-12-09 | Pfizer Products Inc. | Process for the preparation and purification of 1,5-naphthyridine-3-carboxyamides |
WO2004106334A2 (en) * | 2003-05-28 | 2004-12-09 | Pfizer Products Inc. | Process for the preparation of 1,5-naphthyridine-3-carboxy amides by direct ester amidation |
WO2008046135A1 (en) * | 2006-10-16 | 2008-04-24 | Bionomics Limited | Novel anxiolytic compounds |
CA2670116C (en) * | 2006-11-22 | 2015-03-10 | Seaside Therapeutics, Llc | Methods of treating mental retardation, down's syndrome, fragile x syndrome and autism |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR204813A1 (es) * | 1972-05-08 | 1976-03-05 | Yamanouchi Pharma Co Ltd | Proceso para la preparacion de derivados de ampilicina |
GB1433774A (en) * | 1973-02-26 | 1976-04-28 | Allen & Hanburys Ltd | Heterocyclic compounds apparatus for conveying articles |
US4374138A (en) * | 1981-11-13 | 1983-02-15 | Warner-Lambert Company | Antibacterial amide compounds, compositions, and methods of use |
DD279875A1 (de) * | 1987-07-03 | 1990-06-20 | Inst Pharmakologische Forschun | Verfahren zur herstellung von aktivierten carbonsaeureestern |
DD279887A1 (de) * | 1987-07-03 | 1990-06-20 | Inst Pharmakologische Forschun | Verfahren zur herstellung von d-alpha-(4(1h)-1,5-naphthyridon-3-carboxamido)-benzylpenicillin und anderen beta-lactamantibiotika |
DD295360A5 (de) * | 1987-07-03 | 1991-10-31 | Akad Wissenschaften | Verfahren zur Herstellung von aktivierten Carbonsäureestern |
JPS6461461A (en) * | 1987-09-01 | 1989-03-08 | Otsuka Pharma Co Ltd | Benzohetero ring derivative |
-
1998
- 1998-08-24 AU AU91173/98A patent/AU753800B2/en not_active Ceased
- 1998-08-24 WO PCT/US1998/017513 patent/WO1999010347A1/en not_active Application Discontinuation
- 1998-08-24 CN CN98808578A patent/CN1268136A/zh active Pending
- 1998-08-24 PL PL98338783A patent/PL338783A1/xx unknown
- 1998-08-24 BR BR9811362-3A patent/BR9811362A/pt not_active Application Discontinuation
- 1998-08-24 EP EP98943352A patent/EP1007526A1/en not_active Withdrawn
- 1998-08-24 HU HU0003258A patent/HUP0003258A3/hu unknown
- 1998-08-24 NZ NZ502548A patent/NZ502548A/en unknown
- 1998-08-24 CA CA002301599A patent/CA2301599C/en not_active Expired - Fee Related
- 1998-08-24 IL IL13429198A patent/IL134291A0/xx unknown
- 1998-08-24 SK SK216-2000A patent/SK2162000A3/sk unknown
- 1998-08-24 KR KR1020007001948A patent/KR20010023313A/ko not_active Application Discontinuation
- 1998-08-24 SI SI9820055A patent/SI20270A/sl unknown
- 1998-08-24 JP JP2000507675A patent/JP2001514181A/ja active Pending
- 1998-08-24 YU YU10500A patent/YU10500A/sh unknown
- 1998-09-29 EG EG118098A patent/EG21717A/xx active
- 1998-10-23 TW TW87117597A patent/TW574221B/zh active
- 1998-11-13 PE PE1998001100A patent/PE130999A1/es not_active Application Discontinuation
-
2000
- 2000-02-01 AP APAP/P/2000/001742A patent/AP2000001742A0/en unknown
- 2000-02-18 OA OA1200000044A patent/OA11293A/en unknown
- 2000-02-18 NO NO20000822A patent/NO20000822L/no not_active Application Discontinuation
- 2000-02-22 IS IS5382A patent/IS5382A/is unknown
- 2000-02-25 BG BG104192A patent/BG104192A/xx unknown
- 2000-03-16 LV LVP-00-29A patent/LV12539B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1268136A (zh) | 2000-09-27 |
CA2301599C (en) | 2003-03-25 |
JP2001514181A (ja) | 2001-09-11 |
SK2162000A3 (en) | 2001-03-12 |
IS5382A (is) | 2000-02-22 |
PE130999A1 (es) | 1999-12-16 |
WO1999010347A1 (en) | 1999-03-04 |
BG104192A (en) | 2001-05-31 |
IL134291A0 (en) | 2001-04-30 |
EP1007526A1 (en) | 2000-06-14 |
NZ502548A (en) | 2002-06-28 |
AP2000001742A0 (en) | 2000-02-24 |
AU753800B2 (en) | 2002-10-31 |
AU9117398A (en) | 1999-03-16 |
TW574221B (en) | 2004-02-01 |
NO20000822D0 (no) | 2000-02-18 |
BR9811362A (pt) | 2000-08-22 |
CA2301599A1 (en) | 1999-03-04 |
LV12539B (en) | 2001-01-20 |
SI20270A (sl) | 2000-12-31 |
PL338783A1 (en) | 2000-11-20 |
OA11293A (en) | 2002-11-19 |
KR20010023313A (ko) | 2001-03-26 |
YU10500A (sh) | 2002-10-18 |
HUP0003258A3 (en) | 2001-05-28 |
EG21717A (en) | 2002-02-27 |
HUP0003258A2 (en) | 2001-03-28 |
LV12539A (en) | 2000-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20000822L (no) | Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander | |
CA2175204A1 (en) | Certain Fused Pyrrolecarboxanilides; a New Class of GABA Brain Receptor Ligands | |
DE60018274D1 (de) | Substituierte 4-oxo-chinolin-3-carboxamide als gaba gehirnrezeptorliganden | |
HUP0000079A2 (hu) | Indán- és dihidroindolszármazékok | |
MX9805701A (es) | Nuevas pirrolcarboxamidas fusionadas; una nueva clase de ligandos del receptor cerebral gaba. | |
DE69636670D1 (de) | Benzimidazolverbindungen und ihre verwendung als gaba a receptor komplex modulatoren | |
DK0555391T3 (da) | Visse imidazoquinoxaliner; en ny klasse GABA-receptorligander i hjernen | |
BR9608056A (pt) | Compostos de benzimidazol, composições farmacêuticas contendo os compostos e sua utilização. | |
DE69925462D1 (de) | Substituierte cycloalkyl-4-oxonicotinische karboxamide; gaba gehirn-rezeptorligande | |
HUP0303630A2 (hu) | Imidazo-pirimidin-származékok, mint GABA receptorok ligandumai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
AU2321597A (en) | Novel imidazo{1,5-c}quinazolines; a new class of gaba brain receptor ligands | |
WO2021046183A1 (en) | Methods of treating epilepsy using the same | |
BR0009539A (pt) | composto, composição farmacêutica, método para tratamento ou prevenção de uma doença ou distúrbio associado com agonismo patogênico, agonismo inverso ou antagonismo do receptor gaba a, uso de um composto, método para localizar receptores gaba a em uma amostra de tecido, método para alterar a atividade transdutora de sinal de receptores gaba a, método para o tratamento ou prevenção de distúrbios psicológicos associados com modulação do complexo receptor gaba a, e, processo para a preparação de um composto | |
ATE482931T1 (de) | Somatostatinrezeptor-1- und/oder -4-selektive agonisten und antagonisten | |
CA2223936A1 (en) | Novel substituted aryl and cycloalkyl imidazolones; a new class of gaba brain receptor ligands | |
DE69926378D1 (de) | Oxo-pyridoimidazol-carboxamide: gaba-rezeptor-liganden im gehirn | |
MX9709771A (es) | Nuevas aril y cicloalquil imidazolonas substituidas, una clase de ligandos receptores de acido gamma-aminobutirico del cerebro. | |
CA2249562A1 (en) | Certain fused pyrrolecarboxamides as gaba brain receptor ligands | |
BR112019028078A2 (pt) | derivados de 2-oxo-1,3-oxazolidinil imidazotiadiazol | |
AR007742A1 (es) | Pirrolcarboxanilidas fusionadas; una nueva clase de ligandos receptores gaba del cerebro. | |
TH35993A (th) | ฟิวส์ พิร์โรลคาร์บอกแซนิไลด์ | |
BR9807840A (pt) | Derivados de 4-aminoalcóxi-1,3-dihidrobenzoimidazol-2-tionas, sua preparação e seu uso como agonistas de auto-receptor de dopamina (d2) | |
MXPA01006351A (en) | Diphenylurea compounds | |
TH52364A (th) | ปรปักษ์ของตัวรับเบนซอกซาซิโนนโดพามีน d4 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |